Hypoxia, or local lack of oxygen, which develops in aggressive cancer tumors is one of the main obstacles to the ...

Buck County firm Nexgel pulled off a "three-team trade" to acquire six new products, picking up three additional assets in ...

MIT researchers have developed injectable “mini livers” that function as satellite organs, potentially transforming treatment ...

A new technology has been developed to rapidly stop bleeding in patients who need hemostasis. It is expected to be useful for ...

Scientists from Trinity College Dublin and RCSI University of Medicine and Health Sciences have created new “hybrid” immune cells with the potential to help new bone form after a break by ...

Despite the withdrawal of an investor, Langhorne-based Nexgel successfully finalized its acquisition of Celularity’s ...

Circulose and CTA collaborate to use Circulose pulp for lyocell fibers, while Lenzing unveils a three-tier cellulosic fiber ...

The realm of biomaterials engineering has witnessed transformative growth with the advent of functional hydrogels—polymeric networks engineered for ...

This review examines how CAR-T cell therapy is expanding beyond blood cancers into solid tumors, autoimmune diseases, chronic ...

A research team at IDM is leading the development of a sensor that paves the way for the rapid, selective and cost-effective ...

The Shenzhen gala marked the regional debut of a new system innovation, supported by Swiss clinical collaboration and ...

The immune system of people with Type 1 diabetes targets and destroys the pancreatic cells that produce insulin, which is needed to regulate blood sugar levels. Transplanting pancreatic islet cells in ...